Business

SK pharmteco and LOTTE BIOLOGICS Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities

RANCHO CORDOVA, Calif., October 29, 2025--SK pharmteco and LOTTE BIOLOGICS have announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market.

articleSk Inc.October 29, 20253/company/sk-holdings-co-ltd/news/sk-pharmteco-and-lotte-biologics-sign-strategic-partnership-to-strengthen-global-adc-cdmo-capabilities
SK pharmteco and LOTTE BIOLOGICS Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities

About this update from Sk Inc.

[{"type":"image","alt":"Leaders from SK pharmteco and LOTTE BIOLOGICS at the LOTTE BIOLOGICS booth at CPHI Frankfurt, Germany, following the signing of the strategic collaboration Letter of Intent on October 29, 2025. From left to right: Joon Chang, CBO, LOTTE BIOLOGICS; Jiwon Chun, CGO, LOTTE BIOLOGICS; Kern Chang, CTO, LOTTE BIOLOGICS; Yooyeol Shin, CSO, LOTTE BIOLOGICS; James Park, CEO, LOTTE BIOLOGICS; Joerg Ahlgrimm, CEO, SK pharmteco; Andy Fenny, CCO, SK pharmteco; Olivia Boyce, Global Head of Proposals, SK pharmteco; Shiuk Lee, CSO, SK pharmteco; Steve Barr, Head of Small Molecule, SK pharmteco.","displaySize":"","headline":null,"caption":"Leaders from SK pharmteco and LOTTE BIOLOGICS at the LOTTE BIOLOGICS booth at CPHI Frankfurt, Germany, following the signing of the strategic collaboration Letter of Intent on October 29, 2025. From left to right: Joon Chang, CBO, LOTTE BIOLOGICS; Jiwon Chun, CGO, LOTTE BIOLOGICS; Kern Chang, CTO, LOTTE BIOLOGICS; Yooyeol Shin, CSO, LOTTE BIOLOGICS; James Park, CEO, LOTTE BIOLOGICS; Joerg Ahlgrimm, CEO, SK pharmteco; Andy Fenny, CCO, SK pharmteco; Olivia Boyce, Global Head of Proposals, SK pharmteco; Shiuk Lee, CSO, SK pharmteco; Steve Barr, Head of Small Molecule, SK pharmteco.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/c9a6369e67ee9a3808540a034c857a19"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/elN_lhEY9b2600iduQDd1g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c9a6369e67ee9a3808540a034c857a19","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2169,"height":763,"url":"https://media.zenfs.com/en/business-wire.com/4a7656166f0811a70d34d20ed636cfb0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/A3f0yfYphNisSm60E.cGfw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4a7656166f0811a70d34d20ed636cfb0","width":960,"height":338},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/2LGCzY9tnCphBwq0FA4NGA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04NDQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/4a7656166f0811a70d34d20ed636cfb0","width":1200,"heig...

More updates from Sk Inc.

BIOLOGICSLOTTESKJames Parkdrug substanceSK Group